Picture of CERo Therapeutics Holdings logo

CERO — CERo Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial

Dec 17 (Reuters) - CERo Therapeutics Holdings Inc CERO.PK:

CERO THERAPEUTICS PROVIDES CLINICAL UPDATE ON PHASE 1 CLINICAL TRIAL OF CER-1236 IN AML (CERTAINT-1)

Source text: ID:nGNE3H5hTN

Further company coverage: CERO.PK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on CERo Therapeutics Holdings

See all news